Buy Or Sell Opportunity • Apr 13
Now 21% overvalued after recent price rise Over the last 90 days, the stock has risen 9.1% to €251. The fair value is estimated to be €208, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 3.9% over the last 3 years. Earnings per share has grown by 15%. Revenue is forecast to grow by 16% in 2 years. Earnings are forecast to grow by 39% in the next 2 years. Reported Earnings • Mar 31
Full year 2025 earnings released: EPS: €13.40 (vs €11.09 in FY 2024) Full year 2025 results: EPS: €13.40 (up from €11.09 in FY 2024). Revenue: €544.3m (up 10% from FY 2024). Net income: €28.5m (up 22% from FY 2024). Profit margin: 5.2% (up from 4.7% in FY 2024). The increase in margin was driven by higher revenue. Revenue is forecast to grow 7.4% p.a. on average during the next 2 years, compared to a 4.7% growth forecast for the Chemicals industry in France. Over the last 3 years on average, earnings per share has increased by 15% per year but the company’s share price has increased by 46% per year, which means it is tracking significantly ahead of earnings growth. Valuation Update With 7 Day Price Move • Mar 10
Investor sentiment improves as stock rises 19% After last week's 19% share price gain to €285, the stock trades at a forward P/E ratio of 23x. Average forward P/E is 10x in the Chemicals industry in France. Total returns to shareholders of 218% over the past three years. Declared Dividend • Jul 08
Dividend increased to €1.50 Dividend of €1.50 is 50% higher than last year. Ex-date: 9th July 2025 Payment date: 11th July 2025 Dividend yield will be 0.7%, which is lower than the industry average of 1.8%. Payout Ratios Payout ratio: 14%. Cash payout ratio: 8%. Upcoming Dividend • Jul 02
Upcoming dividend of €1.50 per share Eligible shareholders must have bought the stock before 09 July 2025. Payment date: 11 July 2025. Payout ratio is a comfortable 14% and this is well supported by cash flows. Trailing yield: 0.8%. Lower than top quartile of French dividend payers (5.4%). Lower than average of industry peers (2.0%). Duyuru • Jun 04
EPC Groupe (ENXTPA:EXPL) completed the acquisition of Pirobras Industrial LTDA. EPC Groupe (ENXTPA:EXPL) signed an agreement to acquire Pirobras Industrial LTDA on April 3, 2025. Pirobras Industrial is a family-owned company.
This acquisition, which concerns 100% of Pirobras shares, will be fully finalised once the final administrative conditions have been lifted. The transaction does not require any specific authorisations from the French or Brazilian authorities.
EPC Groupe (ENXTPA:EXPL) completed the acquisition of Pirobras Industrial LTDA on June 3, 2025. Duyuru • Apr 04
EPC Groupe (ENXTPA:EXPL) signed an agreement to acquire Pirobras Industrial LTDA. EPC Groupe (ENXTPA:EXPL) signed an agreement to acquire Pirobras Industrial LTDA on April 3, 2025. Pirobras Industrial is a family-owned company.
This acquisition, which concerns 100% of Pirobras shares, will be fully finalised once the final administrative conditions have been lifted. The transaction does not require any specific authorisations from the French or Brazilian authorities. Reported Earnings • Mar 28
Full year 2024 earnings: EPS exceeds analyst expectations Full year 2024 results: EPS: €11.22 (up from €10.16 in FY 2023). Revenue: €494.4m (up 1.4% from FY 2023). Net income: €23.4m (up 9.5% from FY 2023). Profit margin: 4.7% (up from 4.4% in FY 2023). Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 7.2%. Revenue is forecast to grow 5.5% p.a. on average during the next 2 years, compared to a 5.1% growth forecast for the Chemicals industry in France. Over the last 3 years on average, earnings per share has increased by 26% per year but the company’s share price has increased by 47% per year, which means it is tracking significantly ahead of earnings growth. Duyuru • Mar 01
EPC Groupe to Report Fiscal Year 2024 Results on Mar 27, 2025 EPC Groupe announced that they will report fiscal year 2024 results After-Market on Mar 27, 2025 Duyuru • Jan 16
EPC Groupe, Annual General Meeting, Jun 30, 2025 EPC Groupe, Annual General Meeting, Jun 30, 2025. Duyuru • Oct 30
EPC Group Announces Advanced Solutions for Integrating Microsoft 365 Copilot Within Microsoft Fabric EPC Group announced its advanced solutions for integrating Microsoft 365 Copilot within Microsoft Fabric. This enables businesses to generate AI-powered, on-demand reports in Power BI, significantly enhancing their data analysis capabilities. EPC Group was just named the Leader in G2's "Grid for Business Intelligence (BI) Consulting Providers - Fall 2024," as one of North America's top Power BI consulting firms. With Copilot in Fabric, users can ask questions in natural language and receive instant reports with relevant visuals and insights. This eliminates the need for manual report creation and enables agile data exploration. For today's CFOs and Marketing Directors, making swift, data-driven decisions is critical to navigating dynamic market conditions. Microsoft 365 Copilot and Fabric within Power BI have revolutionized this process, providing the ability to instantly drill down into customer segments, sales patterns, and key performance indicators without requiring lengthy manual report-building processes. Imagine the power of asking Power BI, "What are the primary drivers behind its highest repeat customer segments?" Within seconds, Copilot builds an interactive report with all relevant visuals, allowing users toive deep into variables affecting customer loyalty. Marketing Directors can drill down into granular data points to understand what product categories drive the highest customer engagement. Users can customize the report format, making it consistent with existing dashboards, and even add dynamic narrative summaries, which update automatically with refreshed data or new filters. Real-time Reporting in Power BI with Copilot and Fabric: This is Next Level stuff. Leveraging a deep understanding of Microsoft technologies, EPC Group's expert teams focus on building robust, scalable solutions that enhance collaboration, data analytics, and productivity. Through each SharePoint and Power BI project, EPC Group ensures that clients maximize the benefits of their M icrosoft platforms, from seamless information sharing and efficient workflows to dynamic data insights. Launching a 40+ Hour YouTube AI Best Practices & Implementation Series: Sharing extensive knowledge on AI technologies, best practices, and implementation strategies. Early Contributor to Microsoft Technologies: Part of the original SharePoint Beta Team (Project Tahoe) and the new SharePoint Beta team (Project Tahoe) and Marketing Directors (Project Tahoe), EPC Group's Virtual Chief Artificial Intelligence Officer (VCAIO) services offer businesses access to strategic AI expertise without needing a full-time executive. Reported Earnings • Sep 29
First half 2024 earnings released: EPS: €5.94 (vs €5.98 in 1H 2023) First half 2024 results: EPS: €5.94 (down from €5.98 in 1H 2023). Revenue: €243.9m (flat on 1H 2023). Net income: €12.5m (flat on 1H 2023). Profit margin: 5.1% (in line with 1H 2023). Revenue is forecast to grow 4.2% p.a. on average during the next 3 years, compared to a 5.1% growth forecast for the Chemicals industry in France. Over the last 3 years on average, earnings per share has increased by 41% per year but the company’s share price has increased by 49% per year, which means it is tracking significantly ahead of earnings growth. New Risk • Sep 16
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of French stocks, typically moving 6.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (2.9x net interest cover). Minor Risk Share price has been volatile over the past 3 months (6.6% average weekly change). Valuation Update With 7 Day Price Move • Jul 05
Investor sentiment improves as stock rises 19% After last week's 19% share price gain to €154, the stock trades at a trailing P/E ratio of 15.1x. Average forward P/E is 13x in the Chemicals industry in France. Total returns to shareholders of 184% over the past three years. New Risk • May 29
New major risk - Financial position The company's interest payments are not well covered by earnings. Net interest cover: 2.9x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. This is currently the only risk that has been identified for the company. Duyuru • May 26
EPC Groupe, Annual General Meeting, Jun 26, 2024 EPC Groupe, Annual General Meeting, Jun 26, 2024. Location: 142 avenue des champs elysees, paris France Reported Earnings • Mar 31
Full year 2023 earnings released: EPS: €10.16 (vs €8.41 in FY 2022) Full year 2023 results: EPS: €10.16 (up from €8.41 in FY 2022). Revenue: €487.7m (up 3.8% from FY 2022). Net income: €21.3m (up 21% from FY 2022). Profit margin: 4.4% (up from 3.8% in FY 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 81% per year but the company’s share price has only increased by 36% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Mar 27
Investor sentiment improves as stock rises 19% After last week's 19% share price gain to €139, the stock trades at a trailing P/E ratio of 16.1x. Average trailing P/E is 18x in the Chemicals industry in France. Total returns to shareholders of 141% over the past three years. Reported Earnings • Oct 06
First half 2023 earnings released: EPS: €5.98 (vs €5.75 in 1H 2022) First half 2023 results: EPS: €5.98 (up from €5.75 in 1H 2022). Revenue: €244.1m (up 7.0% from 1H 2022). Net income: €12.6m (up 3.9% from 1H 2022). Profit margin: 5.1% (down from 5.3% in 1H 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 113% per year but the company’s share price has only increased by 23% per year, which means it is significantly lagging earnings growth. New Risk • Oct 05
New major risk - Financial position The company's debt is not well covered by operating cash flow. Operating cash flow to total debt ratio: 10% This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. This is currently the only risk that has been identified for the company. New Risk • Aug 13
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of French stocks, typically moving 6.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks High level of debt (52% net debt to equity). Share price has been volatile over the past 3 months (6.1% average weekly change). Valuation Update With 7 Day Price Move • Jun 21
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to €109, the stock trades at a trailing P/E ratio of 13x. Average trailing P/E is 11x in the Chemicals industry in France. Total returns to shareholders of 113% over the past three years. Board Change • Nov 16
Less than half of directors are independent Following the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 5 non-independent directors. Independent Director Nathalie Brunelle Soulas was the last independent director to join the board, commencing their role in 2019. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Valuation Update With 7 Day Price Move • Nov 08
Investor sentiment improved over the past week After last week's 20% share price gain to €98.00, the stock trades at a trailing P/E ratio of 19.2x. Average trailing P/E is 17x in the Chemicals industry in France. Total returns to shareholders of 18% over the past three years. Reported Earnings • Sep 30
First half 2022 earnings released: EPS: €0 (vs €3.57 in 1H 2021) First half 2022 results: EPS: €0. Revenue: €178.2m (down 3.1% from 1H 2021). Net income: €8.30m (up 46% from 1H 2021). Profit margin: 4.7% (up from 3.1% in 1H 2021). The increase in margin was driven by lower expenses. Board Change • Apr 27
Less than half of directors are independent Following the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 5 non-independent directors. Independent Director Nathalie Brunelle Soulas was the last independent director to join the board, commencing their role in 2019. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Reported Earnings • Oct 04
First half 2021 earnings released: EPS €3.57 (vs €11.54 loss in 1H 2020) The company reported a strong first half result with improved earnings, revenues and profit margins. First half 2021 results: Revenue: €183.9m (up 18% from 1H 2020). Net income: €5.68m (up €24.0m from 1H 2020). Profit margin: 3.1% (up from net loss in 1H 2020). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 61 percentage points per year, which is a significant difference in performance. Reported Earnings • Sep 27
First half earnings released Over the last 12 months the company has reported total losses of €27.7m, with earnings decreasing by €34.2m from the prior year. Total revenue was €330.2m over the last 12 months, down 3.1% from the prior year. 
